메뉴 건너뛰기




Volumn 8, Issue 5, 1997, Pages 573-577

Poxviruses as expression vectors

Author keywords

[No Author keywords available]

Indexed keywords

CANCER VACCINE; EPSTEIN BARR VIRUS VACCINE; LIVE VACCINE; RNA POLYMERASE;

EID: 0030696246     PISSN: 09581669     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0958-1669(97)80031-6     Document Type: Article
Times cited : (77)

References (52)
  • 1
    • 0029976870 scopus 로고    scopus 로고
    • Genetically engineered poxviruses for recombinant gene expression, vaccination, and safety
    • Moss B: Genetically engineered poxviruses for recombinant gene expression, vaccination, and safety. Proc Natl Acad Sci USA 1996, 93:11341-11348. A recent review of replicating and non-replicating poxvirus vectors that provides numerous references omitted from the present summary. Includes some background information on the biological properties of poxviruses as related to their use as vectors.
    • (1996) Proc Natl Acad Sci USA , vol.93 , pp. 11341-11348
    • Moss, B.1
  • 2
    • 0029957222 scopus 로고    scopus 로고
    • Applications of pox virus vectors to vaccination: An update
    • Paoletti E: Applications of pox virus vectors to vaccination: an update. Proc Natl Acad Sci USA 1996, 93:11349-11353. A recent review primarily of non-replicating poxvirus vectors developed as vaccine candidates by the author and collaborators.
    • (1996) Proc Natl Acad Sci USA , vol.93 , pp. 11349-11353
    • Paoletti, E.1
  • 3
    • 0013683607 scopus 로고    scopus 로고
    • Vaccinia virus as a live vector for expression of immunogens
    • Edited by Levine MM, Woodrow GC, Kaper JB, Cobon GS. New York: Marcel Dekker
    • Flexner C, Moss B: Vaccinia virus as a live vector for expression of immunogens. In New Generation Vaccines, 2nd edn. Edited by Levine MM, Woodrow GC, Kaper JB, Cobon GS. New York: Marcel Dekker; 1997:297-314. An extensive review of recombinant vaccinia virus vectors, listing many that have been used for expression of immunogens in animal models.
    • (1997) New Generation Vaccines, 2nd Edn. , pp. 297-314
    • Flexner, C.1    Moss, B.2
  • 4
    • 0011880157 scopus 로고
    • A selectable eukaryotic cloning and expression vector
    • Mackett M, Smith GL, Moss B: A selectable eukaryotic cloning and expression vector. Proc Natl Acad Sci USA 1982, 79:7415-7419.
    • (1982) Proc Natl Acad Sci USA , vol.79 , pp. 7415-7419
    • Mackett, M.1    Smith, G.L.2    Moss, B.3
  • 5
    • 0020170245 scopus 로고
    • Construction of poxviruses as cloning vectors: Insertion of the TK gene from herpes simplex virus into the DNA of infectious vaccinia virus
    • Panicali D, Paoletti E: Construction of poxviruses as cloning vectors: insertion of the TK gene from herpes simplex virus into the DNA of infectious vaccinia virus. Proc Natl Acad Sci USA 1982, 79:4927-4931.
    • (1982) Proc Natl Acad Sci USA , vol.79 , pp. 4927-4931
    • Panicali, D.1    Paoletti, E.2
  • 6
    • 85025432190 scopus 로고
    • Generation of recombinant vaccinia viruses
    • Edited by Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, Struhl K. New York: Greene Publishing Associates & Wiley Interscience;
    • Earl PL, Moss B: Generation of recombinant vaccinia viruses. In Current Protocols in Molecular Biology. Edited by Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, Struhl K. New York: Greene Publishing Associates & Wiley Interscience; 1991:16.17.1-16.17.16.
    • (1991) Current Protocols in Molecular Biology , pp. 16171-161716
    • Earl, P.L.1    Moss, B.2
  • 7
    • 0029360471 scopus 로고
    • E. coli β-glucuronidase (GUS) as a marker for recombinant vaccinia viruses
    • Carroll MW, Moss B: E. coli β-glucuronidase (GUS) as a marker for recombinant vaccinia viruses. Bio-Techniques 1995, 19:352-355.
    • (1995) Bio-Techniques , vol.19 , pp. 352-355
    • Carroll, M.W.1    Moss, B.2
  • 8
    • 0029895930 scopus 로고    scopus 로고
    • A vaccinia virus transfer vector using a GUS reporter gene inserted into the 14L locus
    • Howley PM, Spehner D, Drillien R: A vaccinia virus transfer vector using a GUS reporter gene inserted into the 14L locus. Gene 1996, 172:233-237.
    • (1996) Gene , vol.172 , pp. 233-237
    • Howley, P.M.1    Spehner, D.2    Drillien, R.3
  • 9
    • 0031057606 scopus 로고    scopus 로고
    • Gpt-gus fusion gene for selection and marker in recombinant poxviruses
    • Cao J, Upton C: gpt-gus fusion gene for selection and marker in recombinant poxviruses. Bio-Techniques 1997, 22:276-278.
    • (1997) Bio-Techniques , vol.22 , pp. 276-278
    • Cao, J.1    Upton, C.2
  • 10
    • 0028901784 scopus 로고
    • Infection of frog neurons with vaccinia virus permits in vivo expression of foreign proteins
    • Wu G-Y, Zou D-J, Cline HT: Infection of frog neurons with vaccinia virus permits in vivo expression of foreign proteins. Neuron 1995, 14:681-684.
    • (1995) Neuron , vol.14 , pp. 681-684
    • Wu, G.-Y.1    Zou, D.-J.2    Cline, H.T.3
  • 11
    • 0029021814 scopus 로고
    • Selection of recombinant vaccinia viruses on the basis of plaque formation
    • Blasco R, Moss B: Selection of recombinant vaccinia viruses on the basis of plaque formation. Gene 1995, 158:157-162.
    • (1995) Gene , vol.158 , pp. 157-162
    • Blasco, R.1    Moss, B.2
  • 12
    • 0025302978 scopus 로고
    • Transient dominant selection of recombinant vaccinia viruses
    • Falkner FG, Moss B: Transient dominant selection of recombinant vaccinia viruses. J Virol 1990, 64:3108-3111.
    • (1990) J Virol , vol.64 , pp. 3108-3111
    • Falkner, F.G.1    Moss, B.2
  • 13
    • 0025093977 scopus 로고
    • Reverse guanine phosphoribosyltransferase selection of recombinant vaccinia viruses
    • Isaacs SN, Kotwal GJ, Moss B: Reverse guanine phosphoribosyltransferase selection of recombinant vaccinia viruses. Virology 1990, 178:626-630.
    • (1990) Virology , vol.178 , pp. 626-630
    • Isaacs, S.N.1    Kotwal, G.J.2    Moss, B.3
  • 14
    • 0025139856 scopus 로고
    • Construction of fowlpox virus vectors with intergenic insertions: Expression of the β-galactosidase gene and measles virus fusion gene
    • Spehner D, Drillien R, Lecocq J-P: Construction of fowlpox virus vectors with intergenic insertions: expression of the β-galactosidase gene and measles virus fusion gene. J Virol 1990, 64:527-533.
    • (1990) J Virol , vol.64 , pp. 527-533
    • Spehner, D.1    Drillien, R.2    Lecocq, J.-P.3
  • 15
    • 0030956860 scopus 로고    scopus 로고
    • Transient selection during vaccinia virus recombination with insertion vectors without selectable markers
    • Kurilla MG: Transient selection during vaccinia virus recombination with insertion vectors without selectable markers. Bio-Techniques 1997, 22:906-910.
    • (1997) Bio-Techniques , vol.22 , pp. 906-910
    • Kurilla, M.G.1
  • 16
    • 0029558110 scopus 로고
    • A novel vaccinia virus expression system allowing construction of recombinants without the need for selection markers, plasmids and bacterial hosts
    • Pfleiderer M, Falkner FG, Dorner F: A novel vaccinia virus expression system allowing construction of recombinants without the need for selection markers, plasmids and bacterial hosts. J Gen Virol 1995, 76:2957-2962.
    • (1995) J Gen Virol , vol.76 , pp. 2957-2962
    • Pfleiderer, M.1    Falkner, F.G.2    Dorner, F.3
  • 17
    • 0031585554 scopus 로고    scopus 로고
    • Construction and characterisation of vaccinia direct ligation vectors
    • in press
    • Merchlinsky M, Eckert D, Smith E, Zauderer M: Construction and characterisation of vaccinia direct ligation vectors. Virology 1997, in press.
    • (1997) Virology
    • Merchlinsky, M.1    Eckert, D.2    Smith, E.3    Zauderer, M.4
  • 18
    • 0000557448 scopus 로고    scopus 로고
    • Poxviridae: The viruses and their replication
    • Edited by Fields BN, Knipe DM, Howley PM. Philadelphia: Lippincott-Raven Publishers
    • Moss B: Poxviridae: the viruses and their replication. In Fields Virology. Edited by Fields BN, Knipe DM, Howley PM. Philadelphia: Lippincott-Raven Publishers; 1996:2637-2671. This introduction to the biology of poxviruses is recommended to anyone using poxvirus vectors.
    • (1996) Fields Virology , pp. 2637-2671
    • Moss, B.1
  • 19
    • 0030446387 scopus 로고    scopus 로고
    • Development of a replication-deficient recombinant vaccinia virus vaccine effective against parainfluenza virus 3 infection in an animal model
    • Wyatt LS, Shors ST, Murphy BR, Moss B: Development of a replication-deficient recombinant vaccinia virus vaccine effective against parainfluenza virus 3 infection in an animal model. Vaccine 1996, 14:1451-1458. Comparison of strengths of several early/late promoters. Demonstrates immunogenicity of recombinant modified vaccinia virus Ankara by intranasal and intramuscular routes.
    • (1996) Vaccine , vol.14 , pp. 1451-1458
    • Wyatt, L.S.1    Shors, S.T.2    Murphy, B.R.3    Moss, B.4
  • 20
    • 0030862430 scopus 로고    scopus 로고
    • A compact synthetic vaccinia virus early/late promoter for protein expression
    • in press
    • Chakrabarti C, Sisler JR, Moss B: A compact synthetic vaccinia virus early/late promoter for protein expression. Biotechniques 1997, in press.
    • (1997) Biotechniques
    • Chakrabarti, C.1    Sisler, J.R.2    Moss, B.3
  • 21
    • 0030971775 scopus 로고    scopus 로고
    • Construction of a vaccinia virus deficient in the essential DNA repair enzyme uracil DNA glycosylase by a complementing cell line
    • Holzer G, Falkner FG: Construction of a vaccinia virus deficient in the essential DNA repair enzyme uracil DNA glycosylase by a complementing cell line. J Virol 1997, 71:4997-5002. The authors stably transfected a cell line with the vaccinia virus uracil DNA glycoslylase gene, encoding an enzyme required for viral DNA replication. The cells were then used to isolate and propagate a mutant vaccinia virus with a deleted uracil DNA glycosylase gene. In non-permissive cells, prolonged early gene expression was detected, suggesting the potential of the mutant virus as an expression vector.
    • (1997) J Virol , vol.71 , pp. 4997-5002
    • Holzer, G.1    Falkner, F.G.2
  • 22
    • 0029655747 scopus 로고
    • Gene expression and cytopathic effect of vaccinia virus inactivated by psoralen and long-wave UV light
    • Tsung K, Yim JH, Marti W, Buller RML, Norton JA: Gene expression and cytopathic effect of vaccinia virus inactivated by psoralen and long-wave UV light. J Virol 1995, 70:165-171.
    • (1995) J Virol , vol.70 , pp. 165-171
    • Tsung, K.1    Yim, J.H.2    Marti, W.3    Rml, B.4    Norton, J.A.5
  • 23
    • 0029148618 scopus 로고
    • Stringent chemical and thermal regulation of recombinant gene expression by vaccinia virus vectors in mammalian cells
    • Ward GA, Stover CK, Moss B, Fuerst TR: Stringent chemical and thermal regulation of recombinant gene expression by vaccinia virus vectors in mammalian cells. Proc Natl Acad Sci USA 1995, 92:6773-6777.
    • (1995) Proc Natl Acad Sci USA , vol.92 , pp. 6773-6777
    • Ward, G.A.1    Stover, C.K.2    Moss, B.3    Fuerst, T.R.4
  • 24
    • 0029997084 scopus 로고    scopus 로고
    • Recombinant protein synthesis in CHO cells using a vaccinia virus/bacteriophage T7 hybrid expression system
    • Ramsey-Ewing A, Moss B: Recombinant protein synthesis in CHO cells using a vaccinia virus/bacteriophage T7 hybrid expression system. J Biol Chem 1996, 271:16962-16966.
    • (1996) J Biol Chem , vol.271 , pp. 16962-16966
    • Ramsey-Ewing, A.1    Moss, B.2
  • 25
    • 0029033825 scopus 로고
    • Replication-deficient vaccinia virus encoding bacteriophage T7 RNA polymerase for transient gene expression in mammalian cells
    • Wyatt LS, Moss B, Rozenblatt S: Replication-deficient vaccinia virus encoding bacteriophage T7 RNA polymerase for transient gene expression in mammalian cells. Virology 1995, 210:202-205.
    • (1995) Virology , vol.210 , pp. 202-205
    • Wyatt, L.S.1    Moss, B.2    Rozenblatt, S.3
  • 26
    • 0029084129 scopus 로고
    • Non-replicating vaccinia vector efficiently expresses bacteriophage T7 RNA polymerase
    • Sutter G, Ohlmann M, Erfle V: Non-replicating vaccinia vector efficiently expresses bacteriophage T7 RNA polymerase. FEBS Lett 1995, 371:9-12.
    • (1995) FEBS Lett , vol.371 , pp. 9-12
    • Sutter, G.1    Ohlmann, M.2    Erfle, V.3
  • 27
    • 0029897853 scopus 로고    scopus 로고
    • Raccoon poxvirus feline panleukopenia virus VP2 recombinant protects cats against FPV challenge
    • Hu L, Esposito JJ, Scott FW: Raccoon poxvirus feline panleukopenia virus VP2 recombinant protects cats against FPV challenge. Virology 1996, 218:248-252.
    • (1996) Virology , vol.218 , pp. 248-252
    • Hu, L.1    Esposito, J.J.2    Scott, F.W.3
  • 29
    • 0028106471 scopus 로고
    • Recombinant capripoxvirus expressing the hemagglutinin protein gene of rinderpest virus: Protection of cattle against rinderpest and lumpy skin disease
    • Romero CH, Barrett T, Chamberlain RW, Kitching RP, Fleming M, Black DN: Recombinant capripoxvirus expressing the hemagglutinin protein gene of rinderpest virus: protection of cattle against rinderpest and lumpy skin disease. Virology 1994, 204:425-429.
    • (1994) Virology , vol.204 , pp. 425-429
    • Romero, C.H.1    Barrett, T.2    Chamberlain, R.W.3    Kitching, R.P.4    Fleming, M.5    Black, D.N.6
  • 30
    • 0030011043 scopus 로고    scopus 로고
    • Construction of recombinant myxoma viruses expressing genes from different intergenic sites without associated attenuation
    • Jackson RJ, Hall DF, Kerr PJ: Construction of recombinant myxoma viruses expressing genes from different intergenic sites without associated attenuation. J Gen Virol 1996, 77:1569-1575.
    • (1996) J Gen Virol , vol.77 , pp. 1569-1575
    • Jackson, R.J.1    Hall, D.F.2    Kerr, P.J.3
  • 31
    • 0027443053 scopus 로고
    • Fowlpox virus host range restriction: Gene expression, DNA replication, and morphogenesis in nonpermissive mammalian cells
    • Somogyi P, Frazier J, Skinner MA: Fowlpox virus host range restriction: gene expression, DNA replication, and morphogenesis in nonpermissive mammalian cells. Virology 1993, 197:439-444.
    • (1993) Virology , vol.197 , pp. 439-444
    • Somogyi, P.1    Frazier, J.2    Skinner, M.A.3
  • 32
    • 0029923767 scopus 로고    scopus 로고
    • Expression of bacteriophage T7 RNA polymerase in avian and mammalian cells by a recombinant fowlpox virus
    • Britton P, Green P, Kottier S, Mawditt KL, Penzes Z, Cavanaugh D, Skinner MA: Expression of bacteriophage T7 RNA polymerase in avian and mammalian cells by a recombinant fowlpox virus. J Gen Virol 1996, 77:963-967.
    • (1996) J Gen Virol , vol.77 , pp. 963-967
    • Britton, P.1    Green, P.2    Kottier, S.3    Mawditt, K.L.4    Penzes, Z.5    Cavanaugh, D.6    Skinner, M.A.7
  • 33
    • 0030002637 scopus 로고    scopus 로고
    • HIV-1 entry cofactor: Functional cDNA cloning of a seven-transmembrane G protein-coupled receptor
    • Feng Y, Broder CC, Kennedy PE, Berger EA: HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane G protein-coupled receptor. Science 1996, 272:872-877. Outstanding example of the use of the bacteriophage T7-vaccinia virus expression system for screening a cDNA library. This paper describes the discovery of an HIV-1 coreceptor molecule.
    • (1996) Science , vol.272 , pp. 872-877
    • Feng, Y.1    Broder, C.C.2    Kennedy, P.E.3    Berger, E.A.4
  • 34
    • 0030919838 scopus 로고    scopus 로고
    • An infectious clone of human parainfluenza virus type 3
    • Hoffman MA, Banerjee AK: An infectious clone of human parainfluenza virus type 3. J Virol 1997, 71:4272-4277.
    • (1997) J Virol , vol.71 , pp. 4272-4277
    • Hoffman, M.A.1    Banerjee, A.K.2
  • 35
    • 0030467993 scopus 로고    scopus 로고
    • Rescue of a segmented negative-strand RNa virus entirely from cloned complementary DNAs
    • Bridgen A, Elliott RM: Rescue of a segmented negative-strand RNA virus entirely from cloned complementary DNAs. Proc Natl Acad Sci USA 1996, 93:15400-15404. The first report of an infectious segmented RNA virus formed from cDNA. The bacteriophage T7-vaccinia virus expression system was used.
    • (1996) Proc Natl Acad Sci USA , vol.93 , pp. 15400-15404
    • Bridgen, A.1    Elliott, R.M.2
  • 36
    • 0028951218 scopus 로고
    • Vaccinia virus transfection of hippocampal slices
    • Petit DL, Koothan T, Liao D, Malinow R: Vaccinia virus transfection of hippocampal slices. Neuron 1995, 14:685-688.
    • (1995) Neuron , vol.14 , pp. 685-688
    • Petit, D.L.1    Koothan, T.2    Liao, D.3    Malinow, R.4
  • 37
    • 0030897110 scopus 로고    scopus 로고
    • The cytoplasmic and transmembrane domains of the vaccinia virus B5R protein target a chimeric human immunodeficiency virus type 1 glycoprotein to the outer envelope of nascent vaccinia virions
    • Katz E, Wolffe EJ, Moss B: The cytoplasmic and transmembrane domains of the vaccinia virus B5R protein target a chimeric human immunodeficiency virus type 1 glycoprotein to the outer envelope of nascent vaccinia virions. J Virol 1997, 71:3178-3187. The first report of the presentation of a recombinant protein on the surface of vaccinia virus particles. Further work along these lines may lead to targeting of virus particles to specific cells.
    • (1997) J Virol , vol.71 , pp. 3178-3187
    • Katz, E.1    Wolffe, E.J.2    Moss, B.3
  • 38
    • 0029101407 scopus 로고
    • Elimination of fox rabies from Belgium using a recombinant vaccinia-rabies vaccine: An update
    • Brochier B, Costy F, Pastoret PP: Elimination of fox rabies from Belgium using a recombinant vaccinia-rabies vaccine: an update. Vet Microbiol 1995, 46:269-279.
    • (1995) Vet Microbiol , vol.46 , pp. 269-279
    • Brochier, B.1    Costy, F.2    Pastoret, P.P.3
  • 39
    • 0029940996 scopus 로고    scopus 로고
    • Patterns of viral replication correlate with outcome in simian immunodeficiency virus (SIV)-infected macaques: Effect of prior immunization with a trivalent SIV vaccine in modified vaccinia virus Ankara
    • Hirsch VM, Fuerst TR, Sutter G, Carroll MW, Yang LC, Goldstein S, Piatak M Jr, Elkins WR, Alvord WG, Montefiori DC et al.: Patterns of viral replication correlate with outcome in simian immunodeficiency virus (SIV)-infected macaques: effect of prior immunization with a trivalent SIV vaccine in modified vaccinia virus Ankara. J Virol 1996, 70:3741-3752.
    • (1996) J Virol , vol.70 , pp. 3741-3752
    • Hirsch, V.M.1    Fuerst, T.R.2    Sutter, G.3    Carroll, M.W.4    Yang, L.C.5    Goldstein, S.6    Piatak M., Jr.7    Elkins, W.R.8    Alvord, W.G.9    Montefiori, D.C.10
  • 41
    • 0029836437 scopus 로고    scopus 로고
    • Oral immunization with a replication-deficient recombinant vaccinia virus protects mice against influenza
    • Bender BS, Rowe CA, Taylor F, Wyatt LS, Moss B, Small PA: Oral immunization with a replication-deficient recombinant vaccinia virus protects mice against influenza. J Virol 1996, 70:6418-6424.
    • (1996) J Virol , vol.70 , pp. 6418-6424
    • Bender, B.S.1    Rowe, C.A.2    Taylor, F.3    Wyatt, L.S.4    Moss, B.5    Small, P.A.6
  • 42
    • 0029188184 scopus 로고
    • First EBV vaccine trial in humans using recombinant vaccinia virus expressing the major membrane antigen
    • Gu SY, Huang TM, Ruan L, Miao YH, Lu H, Chu CM, Motz M, Wolf H: First EBV vaccine trial in humans using recombinant vaccinia virus expressing the major membrane antigen. Dev Biol Stand 1995, 84:171-177.
    • (1995) Dev Biol Stand , vol.84 , pp. 171-177
    • Gu, S.Y.1    Huang, T.M.2    Ruan, L.3    Miao, Y.H.4    Lu, H.5    Chu, C.M.6    Motz, M.7    Wolf, H.8
  • 43
    • 0029947256 scopus 로고    scopus 로고
    • Human safety and immunogenicity of a canarypoxrabies glycoprotein recombinant vaccine: An alternative poxvirus vector system
    • Fries LF, Tartaglia J, Taylor J, Kauffman EK, Meignier B, Paoletti E, Plotkin S: Human safety and immunogenicity of a canarypoxrabies glycoprotein recombinant vaccine: an alternative poxvirus vector system. Vaccine 1996, 14:428-434. Documentation of the safety and immunogenicity of canarypox vector as a vaccine candidate.
    • (1996) Vaccine , vol.14 , pp. 428-434
    • Fries, L.F.1    Tartaglia, J.2    Taylor, J.3    Kauffman, E.K.4    Meignier, B.5    Paoletti, E.6    Plotkin, S.7
  • 44
    • 0030915310 scopus 로고    scopus 로고
    • Antigen expression by dendritic cells correlates with the therapeutic effectiveness of a model recombinant poxvirus tumor vaccine
    • Bronte V, Carroll MW, Goletz TJ, Wang M, Overwijk WW, Marincola F, Rosenberg SA, Moss B, Restifo NP: Antigen expression by dendritic cells correlates with the therapeutic effectiveness of a model recombinant poxvirus tumor vaccine. Proc Natl Acad Sci USA 1997, 93:3183-3188. This study demonstrates that early expression of tumour antigens is necessary for tumour immunotherapy and antigen presentation. Best results were obtained using a strong synthetic early/late promoter.
    • (1997) Proc Natl Acad Sci USA , vol.93 , pp. 3183-3188
    • Bronte, V.1    Carroll, M.W.2    Goletz, T.J.3    Wang, M.4    Overwijk, W.W.5    Marincola, F.6    Rosenberg, S.A.7    Moss, B.8    Restifo, N.P.9
  • 45
    • 0029007260 scopus 로고
    • Active immunotherapy of cancer with a non- Replicating recombinant fowlpox virus encoding a model tumor-associated antigen
    • Wang M, Bronte V, Chen PW, Gritz L, Panicali D, Rosenberg SA, Restifo NP: Active immunotherapy of cancer with a non- replicating recombinant fowlpox virus encoding a model tumor-associated antigen. J Immunol 1995, 154:4685-4692.
    • (1995) J Immunol , vol.154 , pp. 4685-4692
    • Wang, M.1    Bronte, V.2    Chen, P.W.3    Gritz, L.4    Panicali, D.5    Rosenberg, S.A.6    Restifo, N.P.7
  • 46
    • 0029978501 scopus 로고    scopus 로고
    • P53 as a target for cancer vaccines: Recombinant canarypox virus vectors expressing p53 protect mice against lethal tumor cell challenge
    • Roth J, Dittmer D, Rea D, Tartaglia J, Paoletti E, Levine AJ: p53 as a target for cancer vaccines: recombinant canarypox virus vectors expressing p53 protect mice against lethal tumor cell challenge. Proc Natl Acad Sci USA 1996, 93:4781-4786.
    • (1996) Proc Natl Acad Sci USA , vol.93 , pp. 4781-4786
    • Roth, J.1    Dittmer, D.2    Rea, D.3    Tartaglia, J.4    Paoletti, E.5    Levine, A.J.6
  • 47
    • 0031004055 scopus 로고    scopus 로고
    • Highly attenuated modified vaccinia virus Ankara (MVA) as an effective recombinant vector: A murine tumor model
    • Carroll MW, Overwiijk WW, Chamberlain RS, Rosenberg SA, Moss B, Restifo NP: Highly attenuated modified vaccinia virus Ankara (MVA) as an effective recombinant vector: a murine tumor model. Vaccine 1997, 15:387-394.
    • (1997) Vaccine , vol.15 , pp. 387-394
    • Carroll, M.W.1    Overwiijk, W.W.2    Chamberlain, R.S.3    Rosenberg, S.A.4    Moss, B.5    Restifo, N.P.6
  • 48
    • 0028036728 scopus 로고
    • Induction of antitumor immunity by recombinant vaccinia viruses expressing B7-1 or B7-2 co-stimulatory molecules
    • Hodge JW, Abrams S, Schlom J, Kantor JA: Induction of antitumor immunity by recombinant vaccinia viruses expressing B7-1 or B7-2 co-stimulatory molecules. Cancer Res 1995, 54:5552-5555.
    • (1995) Cancer Res , vol.54 , pp. 5552-5555
    • Hodge, J.W.1    Abrams, S.2    Schlom, J.3    Kantor, J.A.4
  • 49
    • 0029070112 scopus 로고
    • IL-2 enhances the function of recombinant poxvirus-based vaccines in the treatment of established pulmonary metastases
    • Bronte V, Tsung K, Rao JB, Chen PW, Wang M, Rosenberg SA, Restifo NP: IL-2 enhances the function of recombinant poxvirus-based vaccines in the treatment of established pulmonary metastases. J Immunol 1995, 154:5282-5292.
    • (1995) J Immunol , vol.154 , pp. 5282-5292
    • Bronte, V.1    Tsung, K.2    Rao, J.B.3    Chen, P.W.4    Wang, M.5    Rosenberg, S.A.6    Restifo, N.P.7
  • 52
    • 0030228469 scopus 로고    scopus 로고
    • Results of a phase I trial of a recombinant vaccinia virus that expresses carcinoembryonic antigen in patients with advanced colorectal cancer
    • McAneny D, Ryan CA, Beazley RM, Kaufman HL: Results of a phase I trial of a recombinant vaccinia virus that expresses carcinoembryonic antigen in patients with advanced colorectal cancer. Ann Surg Oncol 1996, 3:495-500.
    • (1996) Ann Surg Oncol , vol.3 , pp. 495-500
    • McAneny, D.1    Ryan, C.A.2    Beazley, R.M.3    Kaufman, H.L.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.